Rituximab-Induced Bronchiolitis Obliterans Organizing Pneumonia

Rituximab-induced lung disease (R-ILD) is a rare entity that should be considered in patients treated with rituximab who present with dyspnea, fever, and cough, but no clear evidence of infection. A variety of pathologic findings have been described in this setting. Bronchiolitis obliterans organizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ergin, Ahmet B., Fong, Nancy, Daw, Hamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388422/
https://www.ncbi.nlm.nih.gov/pubmed/22778751
http://dx.doi.org/10.1155/2012/680431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388422/
https://www.ncbi.nlm.nih.gov/pubmed/22778751
http://dx.doi.org/10.1155/2012/680431

Ejemplares similares